Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Interferon-alpha and hydroxyurea in early chronic myeloid leukemia: a comparative analysis of the Italian and German chronic myeloid leukemia trials with interferon-alpha [letter]

J Hasford, M Baccarani, R Hehlmann, H Anseri, S Tura, E Zuffa

Blood (1996) 87 (12): 5384–5391.

https://doi.org/10.1182/blood.V87.12.5384.bloodjournal87125384

Published: 1996

Journal Articles

Interleukin-9 stimulates the proliferation of human myeloid leukemic cells

RM Lemoli, A Fortuna, A Tafuri, M Fogli, M Amabile, A Grande, MR Ricciardi, MT Petrucci, L Bonsi, G Bagnara, G Visani, G Martinelli, S Ferrari, S Tura

Blood (1996) 87 (9): 3852–3859.

https://doi.org/10.1182/blood.V87.9.3852.bloodjournal8793852

Published: 1996

Journal Articles

A new method of "in-cell reverse transcriptase-polymerase chain reaction" for the detection of BCR/ABL transcript in chronic myeloid leukemia patients

N Testoni, G Martinelli, P Farabegoli, A Zaccaria, M Amabile, D Raspadori, S Pelliconi, E Zuffa, C Carboni, S Tura

Blood (1996) 87 (9): 3822–3827.

https://doi.org/10.1182/blood.V87.9.3822.bloodjournal8793822

Published: 1996

Journal Articles

Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells

RM Lemoli, A Fortuna, MR Motta, S Rizzi, V Giudice, A Nannetti, G Martinelli, M Cavo, M Amabile, S Mangianti, M Fogli, R Conte, S Tura

Blood (1996) 87 (4): 1625–1634.

https://doi.org/10.1182/blood.V87.4.1625.bloodjournal8741625

Published: 1996

Journal Articles

Alpha-interferon in the treatment of chronic myeloid leukemia. The Italian Cooperative Study Group on Chronic Myeloid Leukemia [letter; comment]

S Tura, M Baccarani

Blood (1995) 85 (10): 2999–3002.

https://doi.org/10.1182/blood.V85.10.2999.bloodjournal85102999

Published: 1995

Journal Articles

High plasma levels of tumor necrosis factor-alpha may be predictive of veno-occlusive disease in bone marrow transplantation [letter]

L Gugliotta, L Catani, N Vianelli, F Gherlinzoni, MC Miggiano, G Bandini, S Tura

Blood (1994) 83 (8): 2385–2386.

https://doi.org/10.1182/blood.V83.8.2385.2385

Published: 1994

Journal Articles

Interferon-alpha 2a treatment in a pregnant woman with essential thrombocythemia [letter]

N Vianelli, L Gugliotta, S Tura, L Bovicelli, N Rizzo, A Gabrielli

Blood (1994) 83 (3): 874–875.

https://doi.org/10.1182/blood.V83.3.874.874

Published: 1994

Journal Articles

BCR-ABL breakpoint and prognosis in chronic myeloid leukemia [letter; comment]

M Baccarani, G Saglio, A Zaccaria, S Tura

Blood (1992) 79 (9): 2499–2500.

https://doi.org/10.1182/blood.V79.9.2499.2499

Published: 1992

Journal Articles

BCR breakpoint subregions and blast crisis lineage in CML patients [letter; comment]

G Martinelli, A Chiamenti, P Gasparini, PF Pignatti, A Ambrosetti, A Zaccaria, M Buzzi, N Testoni, S Tura, A Guerrasio

Blood (1992) 79 (3): 838–839.

https://doi.org/10.1182/blood.V79.3.838.838

Published: 1992

Journal Articles

Alternative BCR/ABL transcripts in chronic myeloid leukemia [letter; comment]

A Zaccaria, A Tassinari, N Testoni, F Lauria, S Tura, R Algeri, A Guerrasio, C Rosso, G Saglio

Blood (1990) 76 (8): 1663–1665.

https://doi.org/10.1182/blood.V76.8.1663b.1663b

Published: 1990

Journal Articles

Prognostic variables and clinical staging in multiple myeloma

M Cavo, P Galieni, E Zuffa, M Baccarani, M Gobbi, S Tura

Blood (1989) 74 (5): 1774–1780.

https://doi.org/10.1182/blood.V74.5.1774.1774

Published: 1989

Journal Articles

Interferon gamma in chronic myeloid leukemia: dose and side effects [letter]

R Fanin, MG Michieli, C Gallizia, D Damiani, M Baccarani, D Russo, E Zuffa, S Tura

Blood (1988) 72 (4): 1436–1438.

https://doi.org/10.1182/blood.V72.4.1436.1436

Published: 1988

Journal Articles

Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia

JE Sokal, GA Gomez, M Baccarani, S Tura, BD Clarkson, F Cervantes, C Rozman, F Carbonell, B Anger, H Heimpel

Blood (1988) 72 (1): 294–298.

https://doi.org/10.1182/blood.V72.1.294.294

Published: 1988

Journal Articles

Bone marrow transplantation in multiple myeloma: report from the European Cooperative Group for Bone Marrow Transplantation

G Gahrton, S Tura, M Flesch, A Gratwohl, P Gravett, G Lucarelli, M Michallet, J Reiffers, O Ringden, MT van Lint

Blood (1987) 69 (4): 1262–1264.

https://doi.org/10.1182/blood.V69.4.1262.1262

Published: 1987

Journal Articles

Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation

JE Sokal, M Baccarani, S Tura, M Fiacchini, F Cervantes, C Rozman, GA Gomez, DA Galton, GP Canellos, TJ Braun

Blood (1985) 66 (6): 1352–1357.

https://doi.org/10.1182/blood.V66.6.1352.1352

Published: 1985

Journal Articles

Effect of a thymic factor on T lymphocytes in B cell chronic lymphocytic leukemia: in vitro and in vivo studies

F Lauria, D Raspadori, S Tura

Blood (1984) 64 (3): 667–671.

https://doi.org/10.1182/blood.V64.3.667.667

Published: 1984

Journal Articles

Prognostic discrimination in "good-risk" chronic granulocytic leukemia

JE Sokal, EB Cox, M Baccarani, S Tura, GA Gomez, JE Robertson, CY Tso, TJ Braun, BD Clarkson, F Cervantes

Blood (1984) 63 (4): 789–799.

https://doi.org/10.1182/blood.V63.4.789.789

Published: 1984

Journal Articles

Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patients

M Baccarani, G Corbelli, S Amadori, A Drenthe-Schonk, R Willemze, G Meloni, PL Cardozo, C Haanen, F Mandelli, S Tura

Blood (1982) 60 (3): 677–684.

https://doi.org/10.1182/blood.V60.3.677.677

Published: 1982

Journal Articles

Staging of chronic lymphocytic leukemia

M Baccarani, M Cavo, M Gobbi, F Lauria, S Tura

Blood (1982) 59 (6): 1191–1196.

https://doi.org/10.1182/blood.V59.6.1191.1191

Published: 1982

NARROW

Interferon-alpha and hydroxyurea in early chronic myeloid leukemia: a comparative analysis of the Italian and German chronic myeloid leukemia trials with interferon-alpha [letter]

Interleukin-9 stimulates the proliferation of human myeloid leukemic cells

A new method of "in-cell reverse transcriptase-polymerase chain reaction" for the detection of BCR/ABL transcript in chronic myeloid leukemia patients

Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells

Alpha-interferon in the treatment of chronic myeloid leukemia. The Italian Cooperative Study Group on Chronic Myeloid Leukemia [letter; comment]

High plasma levels of tumor necrosis factor-alpha may be predictive of veno-occlusive disease in bone marrow transplantation [letter]

Interferon-alpha 2a treatment in a pregnant woman with essential thrombocythemia [letter]

BCR-ABL breakpoint and prognosis in chronic myeloid leukemia [letter; comment]

BCR breakpoint subregions and blast crisis lineage in CML patients [letter; comment]

Alternative BCR/ABL transcripts in chronic myeloid leukemia [letter; comment]

Prognostic variables and clinical staging in multiple myeloma

Interferon gamma in chronic myeloid leukemia: dose and side effects [letter]

Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia

Bone marrow transplantation in multiple myeloma: report from the European Cooperative Group for Bone Marrow Transplantation

Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation

Effect of a thymic factor on T lymphocytes in B cell chronic lymphocytic leukemia: in vitro and in vivo studies

Prognostic discrimination in "good-risk" chronic granulocytic leukemia

Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patients

Staging of chronic lymphocytic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only